Healthcare industry

Project partners in developing countries will from now on be able to receive DFG funding.

Boehringer Ingelheims research cooperation with the two biotech companies Evotec and Orexo is making good progress. Swedish Orexo AB recently announced that it has extended its three-year research cooperation with Boehringer Ingelheim for another year up to November 2009.

Press release - 21/08/2009

How to organise cooperations effectively

In order for a company to make efficient use of its potential and its specific skills it must focus on its own core competences and on the cooperation with other companies that have supplementary skills. This is all the more important in economically difficult times when investors and banks tend to shy away from investments. The implementation of cooperations between companies raises a number of general issues as well as specific issues relating…

Article - 29/04/2013

‘Autotech meets Biotech’ – current status and outlook

Intensive cooperation between the engineering-driven sectors and the biotechnology sector is a prerequisite for driving forward automation in the field of biotechnology. The Engineering – Life Sciences – Automation (ELSA) cluster initiative of BioRegio STERN Management GmbH aims to promote cross-industry cooperation. A study entitled ‘Biotech meets Autotech’, which was carried out as part of the ELSA project, provides insights into the current…

Article - 10/09/2012

EU cooperations at the interface of research and industry

It is also in the interest of small companies to look beyond their national borders: biotechnology and medical technology specialists in neighbouring European countries offer excellent prospects to German companies – and vice versa. Regional life sciences networks help establish and intensify contacts and collaborative activities between international partners.

Article - 24/03/2008

Successful cooperation between science and industry

At the recent Science meets Business Day four tandem teams of the German BioValley Platform presented their projects. These will be introduced in two articles. The first article focuses on natural substances with a pharmaceutical potential.

The leaders of the two countries research policy groups met in the French capital to discuss strategies on how to cope with challenges that are faced by both countries in the field of research. Several Agreements signed at the end of the Forum are the basis of strategic partnerships.

Press release - 08/04/2010

Next step towards international cooperation

Representatives from companies and research institutes based in the STERN BioRegion met metalworking and surface treatment specialists in France. The collaboration between BioRegio STERN Management GmbH and Ple Technologique de Haute-Champagne PTHC opens up the way for making new contacts sharing innovative ideas and exploring cooperation options.

Press release - 08/04/2010

Launch of FASILIS transnational cooperation forum

On Tuesday 23 March, the Tübingen-Reutlingen Technology Park (TTR) was the destination for entrepreneurs keen to find out more about the FASILIS EU project. This transnational pilot project helps small and medium-sized businesses benefit from the research, infrastructure and service portfolios of the participating European regions. The cooperation forum uses a voucher system to promote innovation and the establishment of new business…

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), and Lonza Group Ltd announced today that they have entered into an exclusive licensing and collaboration agreement for Lonza to commercialize its microCompass™ molecular assays on the BD MAX™ System.

GENOVAC GmbH has announced that it has entered into a research collaboration with ESBATech, a subsidiary of Alcon Biomedical, for the generation of antibodies for use in the field of ophthalmology. Under the terms of the agreement, GENOVAC will use its genetic immunisation technology to generate high-affinity antibodies against molecular targets identified by ESBATech.

Strasbourg, France based NovAliX SAS today announced that it has entered into a definitive agreement to acquire a majority interest in Graffinity Pharmaceuticals GmbH of Heidelberg, Germany, a leading fragment based drug discovery services company. Financial details of the transaction were not disclosed.

Article - 26/08/2013

International procedures for the detection and identification of GM seeds

In Europe the GM contamination threshold must not exceed 0.1. The Agricultural Technology Centre Augustenberg LTZ in Karlsruhe is accredited by the International Seed Testing Association ISTA to carry out international cooperative studies on GM seed analyses in cooperation with ISTA.

If the environment is right and both sides are genuinely interested in working together then the cooperation between biologists and engineers will lead to top technologies. One example of such cooperations is the bioreactors of the Department of Cell Systems at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart.

Press release - 10/03/2011

European Commission and EMBL renew cooperation

In a Memorandum of Understanding signed on march 4th, the European Commission (EC) and the European Molecular Biology Laboratory (EMBL) formalise their desire to maintain and further develop their cooperation.

Article - 25/06/2012

New cooperative research centre on leukaemia established in Ulm

The traditionally strong research into leukaemia at Ulm University is to be further strengthened by the German Research Foundation (DFG). The DFG will fund the new cooperative research centre (SFB) with 8.8 million euros for a period of four years, starting in July 2012. The SFB 1074 “Experimental Models and Clinical Translation in Leukaemias” aims to bring together basic research-oriented and clinical research.

The INTEREG IV B programmes are financial instruments of the European Union designed to support the European-wide cooperation between small- and medium-sized companies, research institutions and government authorities. A meeting held on 22nd July 2009 in Heilbronn provided special information on the programme, with a special focus on the cooperation between North-West and Central Europe.

In the second article in the series on the platforms successful cooperations BioValley presents an encouraging approach for improving the quality of life of severely ill cancer patients and the successful establishment of an industrial biochip platform.

Press release - 22/06/2009

Successful start: cooperative projects of the Rhine-Neckar Biotechnology Cluster (BioRN)

The first joint public appearance of the numerous players of the BioRN top cluster underlines the importance of cooperations between industry and science. At the first annual BioRN conference the Cell-based and molecular medicine top cluster announced the successful start of five cooperative projects funded by the German Federal Ministry of Education and Research. In a strategy workshop the companies involved in the projects presented all 36…

On 26th May 2010, Viscofan BioEngineering announced that it has entered into a 2-year cooperation with the Department of Urology at the University Hospital of Tübingen. Under the terms of the agreement, the company’s “Collagen Cell Carrier” (CCC) will be evaluated in in vitro and pre-clinical models for its suitability as a scaffold for urothelial cells and subsequently as an urological implant. The goal of the cooperation is to enable the use of…

Press release - 21/10/2009

GRAFFINITY enters into drug discovery research collaboration with GENENTECH

HEIDELBERG, October 15, 2009 — Graffinity Pharmaceuticals GmbH announced today that it has entered into a drug discovery research collaboration with Genentech, Inc, a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY). With this collaboration Genentech will gain access to Graffinity’s proprietary, fragment-based drug discovery technology.

Article - 17/10/2011

A European Health Axis

The research clusters of Heidelberg (Germany), Leuven (Belgium) and Cambridge (England) have launched the “Health Axis Europe” initiative, which is aimed at cross-leveraging their innovation resources and working together to increase their international competitiveness by facilitating and coordinating EU-funded collaborative R&D projects, cross-border VC investment and syndication and the cross-border exchange of scientists.

Press release - 20/10/2010

Cytonet cooperates with Hamad Medical Corporation in Doha, Qatar

Joint Venture between Weinheim Biotech-Company Cytonet, the University Children’s Hospital in Heidelberg and the Hamad Medical Corporation (HMC) in Doha, Qatar to promote Liver Cell Therapy.

Dossier - 09/02/2015

Chemical tools for biological applications

The boundaries between traditional scientific disciplines are becoming less and less distinct. Interdisciplinary cooperation is often required to study complex processes and biomolecular issues. Interdisciplinary cooperation is central to chemical biology, a scientific discipline that applies chemical substances, methods and tools to the study of biological systems ranging from the chemical synthesis of biologically active substances to the…

Article - 09/09/2013

The Heinrich-Lanz Centre for Personalised Medicine in Mannheim

A Centre for Translational Research and Personalised Medicine is currently emerging at the Faculty of Medicine in Mannheim, University of Heidelberg. The new centre is expected to boost the development of new therapies in cooperation with partners from Germany and abroad. The centre also works closely with the “French-German Advanced Translational Drug Discovery Center”, a unique, large-scale, cross-border research cooperation between French and…